文献速递外周动脉疾病

中国汉族人群胱抑素C与外周动脉疾病的关联研究

Association between Cystatin C and Peripheral Artery Disease in the Chinese Han Population.
PubMed 文献 · Ann Vasc Surg · 2021-01-01

本研究基于426例中国汉族受试者的病例对照数据,分析胱抑素C与外周动脉疾病(PAD)的关联。结果显示,胱抑素C每升高100 μg/L,PAD风险增加17%;水平≥1.25 mg/L者风险显著更高,且在倾向评分匹配人群中结果一致。ABI<0.4者胱抑素C水平高于ABI≥0.4者。

要点

  • 胱抑素C≥1.25 mg/L与中国汉族人群PAD风险显著升高相关。
  • 胱抑素C每升高100 μg/L,PAD风险增加17%。
  • ABI<0.4者胱抑素C水平高于ABI≥0.4者,提示与PAD严重程度相关。

核心结论

  • 在中国汉族人群中,胱抑素C水平升高与PAD风险增加显著相关。

研究设计与样本

  • 对既往发表的病例对照研究数据进行二次分析,共纳入426名参与者。
  • 采用logistic回归模型及亚组和交互分析,并构建倾向评分匹配人群(164人)验证关联。

主要发现

  • 对照组平均血清胱抑素C浓度显著低于病例组(1.06 ± 0.19 mg/L vs. 1.24 ± 0.34 mg/L,P < 0.001)。
  • 调整传统危险因素后,胱抑素C≥1.25 mg/L者PAD风险显著更高。
  • 血清胱抑素C每升高100 μg/L,PAD风险增加17%。
  • 倾向评分匹配人群(164人)分析结果相似。
  • ABI<0.4患者胱抑素C水平高于ABI≥0.4者(1.31 ± 0.05 mg/L vs. 1.18 ± 0.03 mg/L,P = 0.03)。

临床怎么用

  • 在中国汉族人群中,可关注胱抑素C水平升高者以评估PAD风险。
  • 胱抑素C水平可能与PAD严重程度(ABI分层)相关,可作为辅助评估指标。

局限性

  • 本研究为二次分析,需更大规模的中国前瞻性队列研究验证这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies of the association between cystatin C and peripheral artery disease (PAD) have produced inconsistent results, and few studies have been conducted to investigate this association in the Chinese Han population. Therefore, we evaluated the relationship between cystatin C and PAD using Chinese data. METHODS: We performed a secondary analysis of the data from a previously published case-control study about PAD in our center. We examined the relationship between cystatin C and PAD by logistic regression models and subgroup and interaction analyses. We also constructed a propensity score-matched population by matching the conventional risk factors to further validate this association. In addition, we explored the relationship between cystatin C level and ankle-brachial index (ABI) strata (<0.4, ≥0.4) to shed light on a possible dose-dependent relationship between cystatin C levels and PAD severity. RESULTS: In total, 426 participants were included for evaluation. The mean serum cystatin C concentration was significantly lower in the control group than that in the case group (1.06 ± 0.19 mg/L vs. 1.24 ± 0.34 mg/L, P < 0.001). After adjustment for conventional risk factors, the risk of PAD was significantly higher in individuals with a cystatin C level of ≥1.25 mg/L. A 17% higher risk of PAD was associated with each 100-μg/L increase in the serum cystatin C level. Similar results were seen in the analyses of the propensity score-matched population comprising 164 participants. Furthermore, patients with an ABI <0.4 had higher cystatin C level than those with an ABI ≥0.4 (1.31 ± 0.05 mg/L vs. 1.18 ± 0.03 mg/L, P = 0.03). CONCLUSIONS: Our analysis indicated that an elevated cystatin C level is significantly associated with an increased risk of PAD in the Chinese Han population. Larger Chinese prospective cohort studies are needed to validate these findings.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Deng J, Liu J, Rong D, et al. Association between Cystatin C and Peripheral Artery Disease in the Chinese Han Population. Ann Vasc Surg. 2021. PMID: 33388409. doi:10.1016/j.avsg.2020.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。